Please login to the form below

Not currently logged in
Email:
Password:

La Jolla Pharmaceutical

This page shows the latest La Jolla Pharmaceutical news and features for those working in and with pharma, biotech and healthcare.

Tecentriq’s triple negative breast cancer use among key CHMP nods

Tecentriq’s triple negative breast cancer use among key CHMP nods

Extensions for AZ drugs, new approval for La Jolla. Roche’s Tecentriq has gained a recommendation for approval in triple-negative breast cancer from Europe’s CHMP, setting it on track ... Among other positive news was La Jolla Pharmaceutical’s

Latest news

  • La Jolla plans filing on back of blood pressure trial data La Jolla plans filing on back of blood pressure trial data

    US biotech La Jolla Pharmaceutical added 76% to the value of its shares yesterday after it reported data from a phase III trial showing its drug for low blood pressure. ... La Jolla estimates that there are around half a million distributive shock cases

  • News in brief, May 17, 2007

    Roche inaugurates biotech production centre in Switzerland. Swiss pharmaceutical company Roche has opened a new biotechnology production centre in Basel. ... New CFO for La Jolla Pharmaceuticals. US pharmaceutical company, La Jolla, has hired Niv E

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics